https://stock.noler.com/us/stock/liminal-biosciences-inc https://stock.noler.com/us/stock/liminal-biosciences-inc/accumulated-other-comprehensive-income https://stock.noler.com/us/stock/liminal-biosciences-inc/activist-13d-13g-form-sc-13d https://stock.noler.com/us/stock/liminal-biosciences-inc/activist-13d-13g-form-sc-13g https://stock.noler.com/us/stock/liminal-biosciences-inc/additions-to-rightofuse-assets https://stock.noler.com/us/stock/liminal-biosciences-inc/adjustments-for-deferred-tax-expense https://stock.noler.com/us/stock/liminal-biosciences-inc/adjustments-for-depreciation-expense https://stock.noler.com/us/stock/liminal-biosciences-inc/adjustments-for-fair-value-gains-losses https://stock.noler.com/us/stock/liminal-biosciences-inc/adjustments-for-gain-loss-on-disposal-of-investments-in-subsidiaries-joint-ventures-and-associates https://stock.noler.com/us/stock/liminal-biosciences-inc/adjustments-for-impairment-loss-reversal-of-impairment-loss-recognised-in-profit-or-loss https://stock.noler.com/us/stock/liminal-biosciences-inc/adjustments-for-increase-decrease-in-trade-account-payable https://stock.noler.com/us/stock/liminal-biosciences-inc/adjustments-for-losses-gains-on-disposal-of-noncurrent-assets https://stock.noler.com/us/stock/liminal-biosciences-inc/adjustments-for-provisions https://stock.noler.com/us/stock/liminal-biosciences-inc/adjustments-for-share-based-payments https://stock.noler.com/us/stock/liminal-biosciences-inc/administrative-expense https://stock.noler.com/us/stock/liminal-biosciences-inc/amended-reports-20-f https://stock.noler.com/us/stock/liminal-biosciences-inc/amortisation-expense https://stock.noler.com/us/stock/liminal-biosciences-inc/amortisation-intangible-assets-other-than-goodwill https://stock.noler.com/us/stock/liminal-biosciences-inc/amount-recognised-in-oci-and-accumulated-in-equity-relating-to-noncurrent-assets-or-disposal-groups-held-for-sale https://stock.noler.com/us/stock/liminal-biosciences-inc/applicable-tax-rate https://stock.noler.com/us/stock/liminal-biosciences-inc/average-exercise-price-of-share-options-exercisable-in-share-based-payment-arrangement-2019 https://stock.noler.com/us/stock/liminal-biosciences-inc/average-exercise-price-of-share-options-exercised-in-share-based-payment-arrangement-2019 https://stock.noler.com/us/stock/liminal-biosciences-inc/average-exercise-price-of-share-options-expired-in-share-based-payment-arrangement-2019 https://stock.noler.com/us/stock/liminal-biosciences-inc/average-exercise-price-of-share-options-forfeited-in-share-based-payment-arrangement-2019 https://stock.noler.com/us/stock/liminal-biosciences-inc/average-exercise-price-of-share-options-granted-in-share-based-payment-arrangement-2019 https://stock.noler.com/us/stock/liminal-biosciences-inc/average-exercise-price-of-share-options-outstanding-in-share-based-payment-arrangement-2019 https://stock.noler.com/us/stock/liminal-biosciences-inc/basic-and-diluted-earnings-loss-per-share https://stock.noler.com/us/stock/liminal-biosciences-inc/basic-and-diluted-earnings-loss-per-share-from https://stock.noler.com/us/stock/liminal-biosciences-inc/basic-and-diluted-earnings-loss-per-share-from-discontinued-operations https://stock.noler.com/us/stock/liminal-biosciences-inc/basic-earnings-loss-per-share https://stock.noler.com/us/stock/liminal-biosciences-inc/basic-earnings-loss-per-share-from https://stock.noler.com/us/stock/liminal-biosciences-inc/basic-earnings-loss-per-share-from-discontinued-operations https://stock.noler.com/us/stock/liminal-biosciences-inc/borrowings https://stock.noler.com/us/stock/liminal-biosciences-inc/cash https://stock.noler.com/us/stock/liminal-biosciences-inc/cash-and-cash-equivalents https://stock.noler.com/us/stock/liminal-biosciences-inc/cash-equivalents https://stock.noler.com/us/stock/liminal-biosciences-inc/cash-flows-from-used-in-decrease-increase-in-restricted-cash-and-cash-equivalents https://stock.noler.com/us/stock/liminal-biosciences-inc/cash-flows-from-used-in-financing-activities https://stock.noler.com/us/stock/liminal-biosciences-inc/cash-flows-from-used-in-investing-activities https://stock.noler.com/us/stock/liminal-biosciences-inc/cash-flows-from-used-in-operating-activities https://stock.noler.com/us/stock/liminal-biosciences-inc/cash-flows-from-used-in-operations-before-changes-in-working-capital https://stock.noler.com/us/stock/liminal-biosciences-inc/cash-transferred https://stock.noler.com/us/stock/liminal-biosciences-inc/comprehensive-income https://stock.noler.com/us/stock/liminal-biosciences-inc/comprehensive-income-attributable-to-noncontrolling-interests https://stock.noler.com/us/stock/liminal-biosciences-inc/comprehensive-income-attributable-to-owners-of-parent https://stock.noler.com/us/stock/liminal-biosciences-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/liminal-biosciences-inc/current-assets https://stock.noler.com/us/stock/liminal-biosciences-inc/current-assets-liabilities https://stock.noler.com/us/stock/liminal-biosciences-inc/current-assets-other-than-assets-or-disposal-groups-classified-as-held-for-sale-or-as-held-for-distribution-to-owners https://stock.noler.com/us/stock/liminal-biosciences-inc/current-lease-liabilities https://stock.noler.com/us/stock/liminal-biosciences-inc/current-liabilities https://stock.noler.com/us/stock/liminal-biosciences-inc/current-portion-of-longterm-borrowings https://stock.noler.com/us/stock/liminal-biosciences-inc/current-prepayments-and-other-current-assets https://stock.noler.com/us/stock/liminal-biosciences-inc/current-provisions https://stock.noler.com/us/stock/liminal-biosciences-inc/current-receivables-from-taxes-other-than-income-tax https://stock.noler.com/us/stock/liminal-biosciences-inc/current-restricted-cash-and-cash-equivalents https://stock.noler.com/us/stock/liminal-biosciences-inc/current-tax-assets-current https://stock.noler.com/us/stock/liminal-biosciences-inc/current-tax-assets-noncurrent https://stock.noler.com/us/stock/liminal-biosciences-inc/current-tax-expense-income https://stock.noler.com/us/stock/liminal-biosciences-inc/current-trade-receivables https://stock.noler.com/us/stock/liminal-biosciences-inc/deductible-temporary-differences-for-which-no-deferred-tax-asset-is-recognised https://stock.noler.com/us/stock/liminal-biosciences-inc/deferred-income-classified-as-current https://stock.noler.com/us/stock/liminal-biosciences-inc/deferred-income-classified-as-noncurrent https://stock.noler.com/us/stock/liminal-biosciences-inc/deferred-tax-assets https://stock.noler.com/us/stock/liminal-biosciences-inc/deferred-tax-expense-income https://stock.noler.com/us/stock/liminal-biosciences-inc/deferred-tax-expense-income-recognised-in-profit-or-loss https://stock.noler.com/us/stock/liminal-biosciences-inc/deferred-tax-liability-asset https://stock.noler.com/us/stock/liminal-biosciences-inc/depreciation-and-amortisation-expense https://stock.noler.com/us/stock/liminal-biosciences-inc/depreciation-property-plant-and-equipment https://stock.noler.com/us/stock/liminal-biosciences-inc/depreciation-rightofuse-assets https://stock.noler.com/us/stock/liminal-biosciences-inc/description-of-expected-volatility-share-options-granted https://stock.noler.com/us/stock/liminal-biosciences-inc/description-of-option-life-share-options-granted https://stock.noler.com/us/stock/liminal-biosciences-inc/description-of-risk-free-interest-rate-share-options-granted https://stock.noler.com/us/stock/liminal-biosciences-inc/diluted-earnings-loss-per-share https://stock.noler.com/us/stock/liminal-biosciences-inc/diluted-earnings-loss-per-share-from https://stock.noler.com/us/stock/liminal-biosciences-inc/diluted-earnings-loss-per-share-from-discontinued-operations https://stock.noler.com/us/stock/liminal-biosciences-inc/dividends-paid-ordinary-shares-per-share https://stock.noler.com/us/stock/liminal-biosciences-inc/effect-of-exchange-rate-changes-on-cash-and-cash-equivalents https://stock.noler.com/us/stock/liminal-biosciences-inc/equity https://stock.noler.com/us/stock/liminal-biosciences-inc/equity-and-liabilities https://stock.noler.com/us/stock/liminal-biosciences-inc/equity-attributable-to-owners-of-parent https://stock.noler.com/us/stock/liminal-biosciences-inc/exercise-price-share-options-granted-2019 https://stock.noler.com/us/stock/liminal-biosciences-inc/expected-dividend-as-percentage-share-options-granted https://stock.noler.com/us/stock/liminal-biosciences-inc/expense-from-share-based-payment-transactions-in-which-goods-or-services-received-did-not-qualify-for-recognition-as-assets https://stock.noler.com/us/stock/liminal-biosciences-inc/expense-from-share-based-payment-transactions-with-employees https://stock.noler.com/us/stock/liminal-biosciences-inc/fee-and-commission-income-expense https://stock.noler.com/us/stock/liminal-biosciences-inc/finance-costs https://stock.noler.com/us/stock/liminal-biosciences-inc/financial-assets-at-fair-value-through-profit-or-loss https://stock.noler.com/us/stock/liminal-biosciences-inc/finished-goods https://stock.noler.com/us/stock/liminal-biosciences-inc/form-d-other https://stock.noler.com/us/stock/liminal-biosciences-inc/gain-loss-arising-from-difference-between-carrying-amount-of-financial-liability-extinguished-and-consideration-paid https://stock.noler.com/us/stock/liminal-biosciences-inc/gains-losses-arising-from-sale-and-leaseback-transactions https://stock.noler.com/us/stock/liminal-biosciences-inc/gains-losses-on-exchange-differences-on-translation-recognised-in-profit-or-loss https://stock.noler.com/us/stock/liminal-biosciences-inc/gains-losses-on-financial-assets-at-fair-value-through-profit-or-loss https://stock.noler.com/us/stock/liminal-biosciences-inc/government-grants https://stock.noler.com/us/stock/liminal-biosciences-inc/impairment-loss https://stock.noler.com/us/stock/liminal-biosciences-inc/impairment-loss-recognised-in-profit-or-loss https://stock.noler.com/us/stock/liminal-biosciences-inc/impairment-loss-recognised-in-profit-or-loss-intangible-assets-other-than-goodwill https://stock.noler.com/us/stock/liminal-biosciences-inc/impairment-loss-recognised-in-profit-or-loss-property-plant-and-equipment https://stock.noler.com/us/stock/liminal-biosciences-inc/income-from-attributable-to-owners-of-parent https://stock.noler.com/us/stock/liminal-biosciences-inc/income-from-discontinued-operations-attributable-to-owners-of-parent https://stock.noler.com/us/stock/liminal-biosciences-inc/income-tax-expense https://stock.noler.com/us/stock/liminal-biosciences-inc/increase-decrease-in-cash-and-cash-equivalents-before-effect-of-exchange-rate-changes https://stock.noler.com/us/stock/liminal-biosciences-inc/increase-decrease-in-working-capital https://stock.noler.com/us/stock/liminal-biosciences-inc/increase-decrease-through-conversion-of-convertible-instruments https://stock.noler.com/us/stock/liminal-biosciences-inc/increase-decrease-through-exercise-of-options https://stock.noler.com/us/stock/liminal-biosciences-inc/increase-decrease-through-loss-of-control-of-subsidiary-deferred-tax-liability-asset https://stock.noler.com/us/stock/liminal-biosciences-inc/increase-decrease-through-share-based-payment-transactions https://stock.noler.com/us/stock/liminal-biosciences-inc/intangible-assets-other-than-goodwill https://stock.noler.com/us/stock/liminal-biosciences-inc/interest-expense-on-lease-liabilities https://stock.noler.com/us/stock/liminal-biosciences-inc/interest-paid-classified-as-financing-activities https://stock.noler.com/us/stock/liminal-biosciences-inc/interest-received-classified-as-investing-activities https://stock.noler.com/us/stock/liminal-biosciences-inc/inventories https://stock.noler.com/us/stock/liminal-biosciences-inc/issue-of-equity https://stock.noler.com/us/stock/liminal-biosciences-inc/issued-capital https://stock.noler.com/us/stock/liminal-biosciences-inc/key-management-personnel-compensation https://stock.noler.com/us/stock/liminal-biosciences-inc/key-management-personnel-compensation-postemployment-benefits https://stock.noler.com/us/stock/liminal-biosciences-inc/key-management-personnel-compensation-share-based-payment https://stock.noler.com/us/stock/liminal-biosciences-inc/key-management-personnel-compensation-shortterm-employee-benefits https://stock.noler.com/us/stock/liminal-biosciences-inc/key-management-personnel-compensation-termination-benefits https://stock.noler.com/us/stock/liminal-biosciences-inc/lease-liabilities https://stock.noler.com/us/stock/liminal-biosciences-inc/liabilities-from-share-based-payment-transactions-2011 https://stock.noler.com/us/stock/liminal-biosciences-inc/liabilities-included-in-disposal-groups-classified-as-held-for-sale https://stock.noler.com/us/stock/liminal-biosciences-inc/loans-and-receivables https://stock.noler.com/us/stock/liminal-biosciences-inc/longterm-borrowings https://stock.noler.com/us/stock/liminal-biosciences-inc/longterm-deposits https://stock.noler.com/us/stock/liminal-biosciences-inc/longterm-restructuring-provision https://stock.noler.com/us/stock/liminal-biosciences-inc/noncontrolling-interests https://stock.noler.com/us/stock/liminal-biosciences-inc/noncurrent-assets-or-disposal-groups-classified-as-held-for-sale-or-as-held-for-distribution-to-owners https://stock.noler.com/us/stock/liminal-biosciences-inc/noncurrent-assets-other-than-financial-instruments-deferred-tax-assets-postemployment-benefit-assets-and-rights-arising-under-insurance-contracts https://stock.noler.com/us/stock/liminal-biosciences-inc/noncurrent-lease-liabilities https://stock.noler.com/us/stock/liminal-biosciences-inc/noncurrent-provisions https://stock.noler.com/us/stock/liminal-biosciences-inc/noncurrent-warrant-liability https://stock.noler.com/us/stock/liminal-biosciences-inc/nonderivative-financial-liabilities-undiscounted-cash-flows https://stock.noler.com/us/stock/liminal-biosciences-inc/notional-amount https://stock.noler.com/us/stock/liminal-biosciences-inc/number-of-other-equity-instruments-expired-in-share-based-payment-arrangement https://stock.noler.com/us/stock/liminal-biosciences-inc/number-of-outstanding-share-options https://stock.noler.com/us/stock/liminal-biosciences-inc/number-of-share-options-exercisable-in-share-based-payment-arrangement https://stock.noler.com/us/stock/liminal-biosciences-inc/number-of-share-options-exercised-in-share-based-payment-arrangement https://stock.noler.com/us/stock/liminal-biosciences-inc/number-of-share-options-expired-in-share-based-payment-arrangement https://stock.noler.com/us/stock/liminal-biosciences-inc/number-of-share-options-forfeited-in-share-based-payment-arrangement https://stock.noler.com/us/stock/liminal-biosciences-inc/number-of-share-options-granted-in-share-based-payment-arrangement https://stock.noler.com/us/stock/liminal-biosciences-inc/number-of-shares-issued https://stock.noler.com/us/stock/liminal-biosciences-inc/number-of-shares-issued-and-fully-paid https://stock.noler.com/us/stock/liminal-biosciences-inc/number-of-shares-outstanding https://stock.noler.com/us/stock/liminal-biosciences-inc/other-comprehensive-income https://stock.noler.com/us/stock/liminal-biosciences-inc/other-current-receivables https://stock.noler.com/us/stock/liminal-biosciences-inc/other-liabilities https://stock.noler.com/us/stock/liminal-biosciences-inc/other-noncurrent-assets https://stock.noler.com/us/stock/liminal-biosciences-inc/other-noncurrent-liabilities https://stock.noler.com/us/stock/liminal-biosciences-inc/other-revenue https://stock.noler.com/us/stock/liminal-biosciences-inc/other-tax-effects-for-reconciliation-between-accounting-profit-and-tax-expense-income https://stock.noler.com/us/stock/liminal-biosciences-inc/par-value-per-share https://stock.noler.com/us/stock/liminal-biosciences-inc/payments-of-lease-liabilities-classified-as-financing-activities https://stock.noler.com/us/stock/liminal-biosciences-inc/percentage-of-voting-equity-interests-acquired https://stock.noler.com/us/stock/liminal-biosciences-inc/postemployment-benefit-expense-defined-contribution-plans https://stock.noler.com/us/stock/liminal-biosciences-inc/proceeds-from-borrowings-classified-as-financing-activities https://stock.noler.com/us/stock/liminal-biosciences-inc/proceeds-from-disposal-of-noncurrent-assets-or-disposal-groups-classified-as-held-for-sale-and-discontinued-operations https://stock.noler.com/us/stock/liminal-biosciences-inc/proceeds-from-disposal-or-maturity-of-available-for-sale-financial-assets https://stock.noler.com/us/stock/liminal-biosciences-inc/proceeds-from-exercise-of-options https://stock.noler.com/us/stock/liminal-biosciences-inc/proceeds-from-issue-of-ordinary-shares https://stock.noler.com/us/stock/liminal-biosciences-inc/proceeds-from-issuing-shares https://stock.noler.com/us/stock/liminal-biosciences-inc/proceeds-from-sales-or-maturity-of-financial-instruments-classified-as-investing-activities https://stock.noler.com/us/stock/liminal-biosciences-inc/profit-loss https://stock.noler.com/us/stock/liminal-biosciences-inc/profit-loss-attributable-to-noncontrolling-interests https://stock.noler.com/us/stock/liminal-biosciences-inc/profit-loss-before-tax https://stock.noler.com/us/stock/liminal-biosciences-inc/profit-loss-from https://stock.noler.com/us/stock/liminal-biosciences-inc/profit-loss-from-attributable-to-noncontrolling-interests https://stock.noler.com/us/stock/liminal-biosciences-inc/profit-loss-from-discontinued-operations https://stock.noler.com/us/stock/liminal-biosciences-inc/property-plant-and-equipment https://stock.noler.com/us/stock/liminal-biosciences-inc/proportion-of-ownership-interest-in-subsidiary https://stock.noler.com/us/stock/liminal-biosciences-inc/provisions https://stock.noler.com/us/stock/liminal-biosciences-inc/provisions-for-future-nonparticipating-benefits https://stock.noler.com/us/stock/liminal-biosciences-inc/purchase-of-intangible-assets-classified-as-investing-activities https://stock.noler.com/us/stock/liminal-biosciences-inc/purchase-of-other-longterm-assets-classified-as-investing-activities https://stock.noler.com/us/stock/liminal-biosciences-inc/purchase-of-property-plant-and-equipment-classified-as-investing-activities https://stock.noler.com/us/stock/liminal-biosciences-inc/raw-materials https://stock.noler.com/us/stock/liminal-biosciences-inc/reclassification-adjustments-on-exchange-differences-on-translation-net-of-tax https://stock.noler.com/us/stock/liminal-biosciences-inc/repayments-of-noncurrent-borrowings https://stock.noler.com/us/stock/liminal-biosciences-inc/research-and-development https://stock.noler.com/us/stock/liminal-biosciences-inc/restricted-cash-and-cash-equivalents https://stock.noler.com/us/stock/liminal-biosciences-inc/restructuring-provision https://stock.noler.com/us/stock/liminal-biosciences-inc/retained-earnings https://stock.noler.com/us/stock/liminal-biosciences-inc/revaluation-surplus https://stock.noler.com/us/stock/liminal-biosciences-inc/revenue https://stock.noler.com/us/stock/liminal-biosciences-inc/revenue-from-contracts-with-customers https://stock.noler.com/us/stock/liminal-biosciences-inc/revenue-from-government-grants https://stock.noler.com/us/stock/liminal-biosciences-inc/revenue-from-rendering-of-services https://stock.noler.com/us/stock/liminal-biosciences-inc/revenue-from-royalties https://stock.noler.com/us/stock/liminal-biosciences-inc/revenue-from-sale-of-goods https://stock.noler.com/us/stock/liminal-biosciences-inc/rightofuse-assets https://stock.noler.com/us/stock/liminal-biosciences-inc/sec-comment-letters-corresp https://stock.noler.com/us/stock/liminal-biosciences-inc/sec-comment-letters-upload https://stock.noler.com/us/stock/liminal-biosciences-inc/sec-filings-15-12g https://stock.noler.com/us/stock/liminal-biosciences-inc/sec-filings-20-f https://stock.noler.com/us/stock/liminal-biosciences-inc/sec-filings-25-nse https://stock.noler.com/us/stock/liminal-biosciences-inc/sec-filings-40fr12b https://stock.noler.com/us/stock/liminal-biosciences-inc/sec-filings-6-k https://stock.noler.com/us/stock/liminal-biosciences-inc/sec-filings-cert https://stock.noler.com/us/stock/liminal-biosciences-inc/sec-filings-f-x https://stock.noler.com/us/stock/liminal-biosciences-inc/sec-filings-regdex https://stock.noler.com/us/stock/liminal-biosciences-inc/sec-filings-sc-13e3 https://stock.noler.com/us/stock/liminal-biosciences-inc/sec-filings-suppl https://stock.noler.com/us/stock/liminal-biosciences-inc/secondary-offerings-form-424b3 https://stock.noler.com/us/stock/liminal-biosciences-inc/secondary-offerings-form-drs https://stock.noler.com/us/stock/liminal-biosciences-inc/secondary-offerings-form-effect https://stock.noler.com/us/stock/liminal-biosciences-inc/secondary-offerings-form-f-1 https://stock.noler.com/us/stock/liminal-biosciences-inc/secondary-offerings-form-f-10 https://stock.noler.com/us/stock/liminal-biosciences-inc/secondary-offerings-form-f-3 https://stock.noler.com/us/stock/liminal-biosciences-inc/secondary-offerings-form-pos-am https://stock.noler.com/us/stock/liminal-biosciences-inc/secondary-offerings-form-s-8 https://stock.noler.com/us/stock/liminal-biosciences-inc/secondary-offerings-form-s-8-pos https://stock.noler.com/us/stock/liminal-biosciences-inc/sga-expense https://stock.noler.com/us/stock/liminal-biosciences-inc/share-issue-related-cost https://stock.noler.com/us/stock/liminal-biosciences-inc/share-of-profit-loss-of-associates-and-joint-ventures-accounted-for-using-equity-method https://stock.noler.com/us/stock/liminal-biosciences-inc/shortterm-employee-benefits-accruals https://stock.noler.com/us/stock/liminal-biosciences-inc/shortterm-restructuring-provision https://stock.noler.com/us/stock/liminal-biosciences-inc/tax-effect-from-change-in-tax-rate https://stock.noler.com/us/stock/liminal-biosciences-inc/tax-effect-of-foreign-tax-rates https://stock.noler.com/us/stock/liminal-biosciences-inc/tax-effect-of-tax-losses https://stock.noler.com/us/stock/liminal-biosciences-inc/tax-expense-income-at-applicable-tax-rate https://stock.noler.com/us/stock/liminal-biosciences-inc/tax-expense-relating-to-gain-loss-on-discontinuance https://stock.noler.com/us/stock/liminal-biosciences-inc/tax-expense-relating-to-profit-loss-from-ordinary-activities-of-discontinued-operations https://stock.noler.com/us/stock/liminal-biosciences-inc/total-assets https://stock.noler.com/us/stock/liminal-biosciences-inc/total-liabilities https://stock.noler.com/us/stock/liminal-biosciences-inc/trade-and-other-current-payables https://stock.noler.com/us/stock/liminal-biosciences-inc/trade-and-other-current-payables-to-trade-suppliers https://stock.noler.com/us/stock/liminal-biosciences-inc/trade-and-other-current-receivables https://stock.noler.com/us/stock/liminal-biosciences-inc/trade-and-other-payables-to-trade-suppliers https://stock.noler.com/us/stock/liminal-biosciences-inc/trade-and-other-payables-undiscounted-cash-flows https://stock.noler.com/us/stock/liminal-biosciences-inc/unused-tax-credits-for-which-no-deferred-tax-asset-recognised https://stock.noler.com/us/stock/liminal-biosciences-inc/warrant-liability https://stock.noler.com/us/stock/liminal-biosciences-inc/weighted-average-lessees-incremental-borrowing-rate-applied-to-lease-liabilities-recognised-at-date-of-initial-application-of-ifrs-16 https://stock.noler.com/us/stock/liminal-biosciences-inc/weighted-average-share-price-share-options-granted-2019 https://stock.noler.com/us/stock/liminal-biosciences-inc/weighted-average-shares https://stock.noler.com/us/stock/liminal-biosciences-inc/work-in-progress